AuroMedics Pharma LLC Recall: Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Singl
AuroMedics Pharma LLC Recall: Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Singl is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: AuroMedics Pharma LLC; Product: Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics P
| Recalling firm | AuroMedics Pharma LLC |
|---|---|
| Product | Fondaparinux Sodium Injection, USP, 7.5 mg per 0.6 mL, Single Dose, Prefilled Syringe, Distributed by: AuroMedics Pharma LLC 279 Princeton-Hightstown Rd. E. Windsor, NJ 08520. Made in India. NDC 55150-232-10 (carton)NDC 55150-232-00 (syringe) |
| Reason for recall | Subpotent Drug: Out of specification for assay |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Terminated |
| Distribution | Nationwide in the USA |
| Recall initiated | 20220930 |
| Recall number | D-0020-2023 |
| Category | drug |
| State | NJ |
| Country | United States |
$29/mo
Try RecallGuard →